Norbornene modified peptides and their labelling with tetrazine compounds
US9968690B2 · kind B2 · utility
3Cited by
0References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 21, 2013 |
| Grant date | May 15, 2018 |
| Priority date | — |
| Expiry date | Sep 23, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/42
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a polypeptide comprising an amino acid having a norbornene group. Suitably said norbornene group is present as an amino acid residue of a norbornene lysine. The invention also relates to a method of producing a polypeptide comprising a norbornene group, said method comprising genetically incorporating an amino acid comprising a norbornene group into a polypeptide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.